Patient resources
Getting started on Trajenta® (linagliptin)
This video can be shown to your patients prescribed Trajenta during their appointment, but please do not share this webpage.
Click below to view other available languages:
Downloadable Document
What has diabetes got to do with my kidneys?
Print and share this leaflet with your patients, which explains the relationship between diabetes and CKD, the importance of regular blood and urine testing, and strategies for slowing CKD progression
Written in collaboration with Sanjay Mistry, an expert through experience
Downloadable Document
Supporting your patients during Ramadan
This leaflet, designed for patients, outlines the key considerations a person with diabetes should be aware of when planning to fast during Ramadan
Includes a link to a patient video discussing considerations prior to Ramadan fasting
Abbreviation:
CKD: chronic kidney disease
Trajenta is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control as:
monotherapy when metformin is inappropriate due to intolerance, or contraindicated due to renal impairment
in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control
PC-GB-110506 V2 | July 2025